Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-02

FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)

View source ↗

Summary

FDA approved Mayne Pharma's supplemental application for isotretinoin. The action indicates a labeling or formulation update under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)